Precision therapeutics for rare diseases as well as complex oncology cases is an area that may benefit from Agentic AI Closed-Loop (AACL) systems to enable individualized treatment optimization — a continuous process of proposing, testing, and adapting therapies for a single patient (N-of-1 trials). N-of-1 problems are not typical for either clinicians or data systems. […]
Posts Tagged ‘Model governance’